Stay updated with breaking news from Lead Identification Suite. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A large number of pharmaceutical companies are now taking the help of AI to develop drugs. Google Cloud has unveiled two new suites of AI tools that aim to help the pharmaceutical industry accelerate drug discovery and make it cheaper.
Improved drug discovery and innovations in personalized treatments are among the goals for the new Target and Lead Identification Suite and Multiomics Suite.
The Target and Lead Identification Suite aims to streamline the first key step of drug development, which is identifying a biological target that researchers…
The solutions mark Google’s latest advancements in the AI arms race and hope to address a long-standing issue facing biotech and pharmaceutical companies.
Google Cloud launched AI-powered tools to accelerate drug discovery and precision medicine.